pI: 7.383 |
Length (AA): 743 |
MW (Da): 84361 |
Paralog Number:
2
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 8 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
34 | 139 | 1r75 (A) | 12 | 128 | 19.00 | 0 | 0.5 | 0.38 | -0.56 |
150 | 743 | 1qxp (A) | 2 | 622 | 21.00 | 0 | 1 | 0.64 | 0.77 |
169 | 537 | 1zcm (A) | 39 | 353 | 27.00 | 0 | 1 | 0.66 | -0.26 |
34 | 130 | 1r75 (A) | 12 | 118 | 20.00 | 0 | 0.18 | 0.310852 | -0.25 |
156 | 743 | 1df0 (A) | 11 | 588 | 19.00 | 0 | 1 | 0.576686 | 1.12 |
158 | 469 | 2nqa (A) | 23 | 302 | 33.00 | 0.000000000013 | 1 | 0.523419 | 0.88 |
169 | 537 | 1zcm (A) | 39 | 353 | 25.00 | 0 | 1 | 0.601935 | 0.42 |
691 | 742 | 1k94 (A) | 54 | 104 | 12.00 | 0.00005 | 0.01 | 0.190287 | -0.22 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_166755)
Species | Accession | Gene Product |
---|---|---|
Leishmania braziliensis | LbrM.31.0520 | calpain-like protein, putative,cysteine peptidase, Clan CA, family C2, putative |
Leishmania donovani | LdBPK_310420.1 | calpain-like protein, putative |
Leishmania infantum | LinJ.31.0420 | calpain-like protein, putative,cysteine peptidase, Clan CA, family C2, putative |
Leishmania major | LmjF.31.0400 | calpain-like protein, putative,cysteine peptidase, Clan CA, family C2, putative |
Leishmania mexicana | LmxM.30.0400 | calpain-like protein, putative,cysteine peptidase, Clan CA, family C2, putative |
Trypanosoma cruzi | TcCLB.508555.70 | calpain-like cysteine peptidase, putative |
Trypanosoma cruzi | TcCLB.509237.140 | calpain-like cysteine peptidase, putative |
Trypanosoma cruzi | TcCLB.477983.10 | calpain cysteine peptidase, putative |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Leishmania major | calpain-like protein, putative,cysteine peptidase, Clan CA, family C2, putative | Compounds | References |
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Leishmania major | cytoskeleton-associated protein CAP5.5, putative,cysteine peptidase, Clan CA, family C2, putative | 723 aa | 25.1% | 680 aa | Compounds | References |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 414 aa | 29.3% | 365 aa | Compounds | References |
Leishmania major | calpain family cysteine protease-like protein | 705 aa | 26.2% | 737 aa | Compounds | References |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 732 aa | 27.6% | 721 aa | Compounds | References |
Leishmania major | calpain-like cysteine peptidase, putative,cysteine peptidase, Clan CA, family C2, putative | 687 aa | 29.0% | 690 aa | Compounds | References |